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Aim of this paper was to evaluate the effects of changes in obesity status on lung function
decline over an 8-year follow-up.
Adults over 24 years (n ¼ 1212) from the general population, who participated in both Po
River Delta first (PD1, 1980–1982) and second (PD2, 1988–1991) epidemiological surveys,
were stratified as ‘‘never obese’’ (BMIo30 Kg/m2 at both PD1 and PD2), ‘‘becoming obese’’
(BMIo30 Kg/m2 at PD1 and X30 Kg/m2 at PD2), ‘‘always obese’’ (BMIX30 Kg/m2 at both
PD1 and PD2), and ‘‘becoming non-obese’’ (BMIX30 Kg/m2 at PD1 ando30 Kg/m2 at PD2).
Linear regression models for changes in FEV1, FVC, and VC (computed as absolute
differences between the values at PD2 and those at PD1) with longitudinal categories of
obesity, gender, age, and baseline smoking habits as covariates were applied.
The ‘‘becoming obese’’ and ‘‘always obese’’ categories had a significantly greater decline
of lung function than ‘‘never obese’’ group; in the ‘‘always obese’’ group, this was true for
vital capacities but not FEV1. Conversely, in the ‘‘becoming non-obese’’ group lung
function was at PD2 improved with respect to PD1. Compared with ‘‘Never obese’’ the
mean increase in lung function was of 93, 180, and 48mL for FEV1, FVC, and VC,
respectively.
In this general population sample, remaining or becoming obese increases the decline in
lung function over 8 years, while becoming non-obese decreases it.
& 2008 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
ry Environmental Epidemiology Unit, CNR Institute of Clinical Physiology, Via Trieste, 41, Pisa 56126,
3153701.
ifc.cnr.it (F. Pistelli).
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Obesity and lung function decline 675Introduction flow sample before a 2 s interval where each flow value wasObesity is becoming a social and economical problem in the
Western World for the numerous respiratory, cardiovascular,
and metabolic diseases associated with the increase in body
mass.1,2 Whereas most of the organs or systems of the body
slowly react to obesity, the respiratory system quickly
adapts by reducing lung volumes and airway caliber.3–5 As
a result, gas exchange worsens,6 and dynamic compression
of the airways downstream from the flow limiting segments
occurs,7 thus explaining symptoms and exercise limitation
complained by obese individuals even when their spirometry
is still normal or near normal.
Few longitudinal studies have consistently shown that
obesity is associated with higher lung function decline.8–12
Thus, obesity may alter lung function not only by reducing
lung volume and airway caliber but also by accelerating the
decline in lung function. However, to our knowledge, scanty
information is available about the effects of changes in
obesity status on lung function decline. The availability of
existing longitudinal data from an epidemiological popula-
tion-based study carried out in 1980s gave us the opportu-
nity to explore this possible association of current
respiratory interest.
This study aimed to evaluate in a general population
whether changes in obesity status may accelerate or slow
down the decline in lung function over an 8-year follow-up.
Material and methods
Study subjects
The present study was performed on 1212 subjects who
participated in both the first (PD1) and second (PD2)
epidemiological surveys carried out in 1980–1982 and
1988–1991, respectively, on the general population living
in the rural area of Po River Delta in Italy. Details of the
study design and results of PD study have been previously
published.13–15 Only subjects aged over 24 years at baseline
and with complete questionnaire follow-up were included.
Study subjects provided verbal informed consent to volun-
tarily participate in both PD1 and PD2 epidemiological (non-
pharmaceutical) surveys. Italian law did not request the
approval of Ethical Committee at the time of the field
surveys.
Lung function measurements
At both surveys, the same instrument was used for lung
function measurements (Fleish no. 3 pneumotachograph,
Pulmonary System 47804/S, Hewlett-Packard, Waltham,
Massachusetts, USA). The pneumotachograph was heated
at 37 1C, and volumes reported in liters at BTPS. Volume
calibration was performed daily using a standard 3 L
calibrated syringe. The protocol for lung function measure-
ments fulfilled the American Thoracic Society (ATS) recom-
mendations16 at both surveys, with the exception of the
criterion for the end-point of the forced vital capacity (FVC)
maneuver17 (e.g., for FVC maneuvers with an expiration
timeo16 s, the end-point occurred either at the last flow
sample before an inspiratory volume4250mL or at the lasto15mL/s; the ATS algorithm instead determined the end-
point when the average flow during a 0.5 s interval was less
than 50mL/s). Up to eight forced expiratory maneuvers
were performed to obtain at least three acceptable
spirograms. The two largest FVC and forced expiratory
volume in 1 s (FEV1) values from all acceptable maneuvers
had to be within 5% from each other. The largest FVC and
FEV1 were selected regardless of the maneuver. At least two
attempts were repeated to obtain a satisfactory slow vital
capacity (VC) and the largest value was retained for
statistical analysis. Percent predicted values for FEV1,
FVC, and VC were computed according to reference
equations derived within PD1 normals.13Variables of interest
The body mass index (BMI) was computed as the ratio of
body weight in kilograms to squared-height in meters. On
the basis of BMI variations in over time, subjects were
stratified into four categories: ‘‘never obese’’ (NO), BMIo30 Kg/m2 at both PD1 and
PD2; ‘‘becoming obese’’ (BO), BMIo30 Kg/m2 at PD1 and
X30 Kg/m2 at PD2; ‘‘always obese’’ (AO), BMIX30 Kg/m2 at both PD1 and
PD2; ‘‘becoming non-obese’’ (BNO), BMIX30 Kg/m2 at PD1
and o30 Kg/m2 at PD2.Height (in centimeters) and weight (in kilograms) were
measured in standing position without shoes in subjects
wearing clothes. Age at last birthday was recorded. Subjects
were defined as ‘‘current smokers’’, ‘‘ex-smokers’’, and
‘‘never smokers’’ on the basis of smoking habit as reported
at PD1.
For each subject, longitudinal variation in FEV1, FVC, and
VC was computed as the difference between measurements
taken at PD2 and at PD1. Throughout the paper we refer to
the variations as DFEV1, DFVC, and DVC.Statistical analysis
The distributions of the variables were compared across
categories of obesity, separately by gender. P values for the
differences among categories were obtained by non-para-
metric Kruskal–Wallis test. P values less than 5% were
considered statistically significant.
Linear regression models were applied to estimate mean
DFEV1, DFVC, and DVC as functions of obesity categories
(4-level categorical variable, reference category NO),
gender (binary, reference category females), smoking habit
(3-level, reference category never smokers), and age at
baseline (continuous, in years). The linearity assumption for
the relationship between age and the conditional mean of
the outcome variables were tested by means of indicator
variables for the quartiles of age. P values were calculated
by Wald test. Pairwise interactions among covariates were
not statistically significant.
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Baseline characteristics of the study subjects are reported in
Table 1. In both genders: NO had significant lower mean age;
AO had significantly higher mean BMI than BNO and, by
selection criteria, than BO and NO; mean absolute and
percent predicted values of FEV1, FVC, and VC were the
lowest in BNO and the largest in NO and BO. Furthermore,
there were statistically significant differences for absolute
values across groups in both genders, and for percent
predicted values of FVC and VC in females.
Mean absolute differences between values at PD2 and PD1
are reported in Table 2, where negative values of DFEV1,
DFVC, and DVC denote decrease in lung function. The mean
increase of weight in BO was around 9 Kg in both genders;
the mean decrease of weight in BNO was about 9 Kg in males
and 10 Kg in females. Accordingly, BMI increased in BO by
about 4 Kg/m2 in both genders while decreased in BNO by
about 3 Kg/m2 in males and 4 Kg/m2 in females. While mean
decline in FEV1 for males was 29mL in BO and 16mL in AO, it
was only 2mL in BNO. Corresponding figures for females
were 30, 23, and 16mL. Mean decline in FVC for males was
28mL in BO and 21mL AO, while a mean increase of 4mL in
FVC over time was observed in BNO. Similar values were
observed for VC in males. In females, mean decline of FVC
and VC in BO and AO was 27mL on average. In BNO females,
a mean decline of 3 and 16mL for FVC and VC, respectively,
was observed. In both genders, DFEV1, DFVC, and DVC were
statistically different across groups, with BNO showing the
lowest mean values; in BNO males, FVC and VC on average
increased at follow-up.
Table 3 show the mean DFEV1, DFVC, and DVC values as
coefficients of linear regression models in longitudinal
categories of obesity adjusted for baseline gender, age,Table 1 Baseline characteristics of study subjects by longitudi
Males (n ¼ 590)
Never
obese
Becoming
obese
Always
obese
Becoming
non-obese
P
n 465 55 57 13
Age
(years)
41 (11) 44 (11) 45 (10) 48 (7) 0.00
Height
(cm)
171 (7) 171 (7) 170 (7) 169(5) 0.36
Weight
(kg)
73 (8) 81 (10) 93 (10) 88 (6) 0.00
BMI (kg/
m2)
25 (2) 28 (2) 32 (2) 31 (1) 0.00
FEV1 (L) 3.6 (0.7) 3.5 (0.8) 3.3 (0.7) 3.0 (0.7) 0.00
FEV1
(%pred)
95 (15) 94 (16) 94 (16) 89 (18) 0.57
FVC (L) 4.8 (0.8) 4.7 (0.9) 4.4 (0.8) 4.1 (0.6) 0.00
FVC
(%pred)
98 (12) 98 (12) 98 (13) 92 (11) 0.29
VC (L) 4.9 (0.8) 4.9 (0.9) 4.6 (0.8) 4.2 (0.7) 0.00
VC (%pred) 98 (13) 97 (11) 96 (14) 89 (12) 0.08
Data presented are mean (SD). P-value across longitudinal categorieand smoking habit. With respect to the reference category
(NO), BO had a greater and statistically significant decline in
lung function, which was of 111,122, and 155mL for FEV1,
FVC, and VC, respectively. The corresponding figures in AO
were 9, 65, and 109mL, and a statistically significant
difference was observed only for FVC and VC. In contrast,
BNO yielded positive coefficients for the changes of all
three spirometric parameters (statistically significant for
DFEV1 and DFVC), thus suggesting a reduced lung function
decline. Compared with NO, the mean increase in lung
function was of 93, 180, and 48mL for FEV1, FVC, and VC,
respectively. Estimated coefficients of DFEV1, DFVC, and
DVC were always significantly different (Po0.05) among the
longitudinal categories of obesity, with the exception of
DFVC and DVC between BO and AO. Age coefficient was
always negative and statistically significant, due to the
natural decline of lung function with age. The decrease in
FEV1 was slightly but significantly greater in women than
men. The decrease in FEV1, FVC, and VC was significantly
greater in smokers than in never smokers. Interestingly, the
ex-smokers showed a positive DFEV1 coefficient, thus
suggesting a relative improvement in lung function over
time. The larger decline of the spirometric parameters over
time in BO and AO and the reverted trend in BNO
are highlighted graphically in Figure 1 and numerically in
Figure 2.
Having cardiac disorder(s) was reported by 19.5% of the
subjects of both genders and was a significant predictor only
for DFEV1 and DFVC, but it did not affect the estimates of
the coefficient of the categories of obesity (i.e., it was not a
confounding factor). Having diabetes was reported by 2.9%
of the subjects of both genders and was neither a significant
predictor of changes in lung function nor a confounding
factor in any model considered.nal category of obesity and gender.
Females (n ¼ 622)
Never
obese
Becoming
obese
Always
obese
Becoming
non-obese
P
474 56 75 17
06 41 (11) 43 (10) 48 (10) 47 (10) 0.0000
61 158 (5) 157 (7) 156 (5) 155 (5) 0.0001
00 60 (8) 69 (7) 82 (10) 77 (7) 0.0000
00 24 (3) 28 (2) 34 (3) 32 (2) 0.0000
10 2.7 (0.4) 2.7 (0.5) 2.5 (0.4) 2.5 (0.3) 0.0000
80 98 (12) 98 (13) 96 (11) 96 (11) 0.1057
03 3.5 (0.5) 3.5 (0.5) 3.2 (0.5) 3.0 (0.4) 0.0000
22 99 (12) 98 (12) 96 (10) 91 (11) 0.0004
20 3.6 (0.5) 3.6 (0.5) 3.4 (0.5) 3.2 (0.4) 0.0000
75 99 (12) 98 (13) 96 (11) 92 (10) 0.0038
s of obesity by Kruskal–Wallis test.
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Table 2 Mean absolute differences between values observed at follow-up and at baseline by longitudinal categories of
obesity and gender.
Males (n ¼ 590) Females (n ¼ 623)
Never
obese
Becoming
obese
Always
obese
Becoming
non-obese
P Never
obese
Becoming
obese
Always
obese
Becoming
non-obese
P
n 465 55 57 13 474 56 75 17
Age (years) 8.2
(0.9)
8.3
(1.0)
8.1
(0.9)
8.3
(0.9)
0.5835 8.2
(0.9)
8.5
(1.0)
8.3
(0.9)
8.2
(0.6)
0.3108
Height (cm) 1.0
(1.9)
1.6
(2.1)
0.9
(1.8)
0.4
(1.7)
0.1047 0.7
(2.0)
1.4
(1.8)
1.1
(1.9)
0.8
(1.9)
0.0003
Weight (kg) 1.7
(4.9)
9.2
(7.9)
2.7
(6.6)
8.9
(9.8)
0.0000 2.0
(4.6)
8.8
(5.5)
1.1
(5.9)
9.8
(8.8)
0.0000
BMI
(kg/m2)
0.9
(1.7)
3.7
(2.6)
1.3
(2.4)
2.9
(3.2)
0.0000 1.0
(1.9)
4.1
(2.2)
0.9
(2.7)
4.4
(3.4)
0.0000
DFEV1 (L) 0.17
(0.27)
0.29
(0.23)
0.16
(0.20)
0.02
(0.31)
0.0007 0.18
(0.19)
0.30
(0.20)
0.23
(0.19)
0.16
(0.19)
0.0000
DFVC (L) 0.13
(0.32)
0.28
(0.31)
0.21
(0.25)
0.04
(0.41)
0.0015 0.14
(0.24)
0.28
(0.27)
0.26
(0.22)
0.03
(0.35)
0.0000
DVC (L) 0.10
(0.37)
0.27
(0.30)
0.18
(0.31)
0.02
(0.39)
0.0015 0.09
(0.26)
0.27
(0.28)
0.28
(0.29)
0.16
(0.21)
0.0000
Data presented are mean (SD). P-value across longitudinal categories of obesity by Kruskal–Wallis test.
Table 3 Estimated coefficients of the linear regression models for the variation of FEV1 (DFEV1), FVC (DFVC), and VC (DVC)
in longitudinal categories of obesity, adjusted for sex, baseline age, and smoking habits.
DFEV1 (L) DFVC (L) DVC (L)
Coeffi-
cient
P 95%
C.I.
Coeffi-
cient
P 95%
C.I.
Coeffi-
cient
P 95%
C.I.
Becoming
obese
0.111 0.000 0.157 0.065 0.122 0.000 0.179 0.066 0.155 0.000 0.216 0.094
Always obese 0.009 0.694 0.052 0.034 0.065 0.017 0.118 0.011 0.109 0.000 0.167 0.051
Becoming non-
obese
0.093 0.037 0.006 0.180 0.180 0.001 0.072 0.287 0.048 0.406 0.066 0.162
Smoker 0.050 0.002 0.081 0.019 0.023 0.237 0.062 0.015 0.025 0.254 0.068 0.017
Ex smoker 0.013 0.525 0.028 0.055 0.011 0.687 0.062 0.041 0.006 0.823 0.063 0.050
Male sex 0.029 0.049 0.000 0.059 0.021 0.250 0.015 0.057 0.015 0.466 0.025 0.055
Age 0.004 0.000 0.005 0.003 0.007 0.000 0.008 0.005 0.006 0.000 0.007 0.004
Constant 0.001 0.975 0.068 0.066 0.150 0.000 0.068 0.233 0.146 0.002 0.055 0.237
DFEV1, DFVC, and DVC are computed as the FEV1, FVC, and VC value (in L) measured at follow-up minus the value at baseline. 95%
C.I. ¼ 95% confidence intervals.
Obesity and lung function decline 677Discussion
The main findings of this study are that (1) obesity entails a
faster but variable reduction of the spirometric parameters
most representative for lung function decline and (2) loosing
weight appears to be capable of diminishing the lung
function decline linked to obesity. These findings may
support the notion that obesity and lung function are tightly
linked in a reversible but complex way.Epidemiological evidences
Our findings are consistent with those from previous long-
itudinal studies, which demonstrated that weight gainaffects lung function independently of age, smoking habit,
and occupational exposure both in population-based8,11,12
and occupational cohorts.9,10 Thus, the relevant association
between increasing weight and an accelerated decline in
lung function is confirmed in this general population, where
even small changes in adiposity affected lung function
decline over an 8-year period of time.
We also observed that this trend may be reverted with
weight loss. To our knowledge, no large longitudinal
population-based study has specifically analyzed the effect
of the reversibility of the obesity status on lung function
decline. In a random sample of 9003 adults, Carey et al.12
observed that subjects who lost weight between two surveys
conducted 7 years apart did not on average gain lung
function, but rather slowed down their rate of decline in
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Figure 1 Mean variations (in liters) of DFEV1, DFVC and DVC in three longitudinal categories of obesity with respect to the
reference category of ‘‘never obese’’, based on the linear regression models reported in Table 3. Within each longitudinal category of
obesity, the three bars refer to DFEV1, (black circle), DFVC (open circle), and DVC (open square) from left to right, respectively.
n = 1212 
8-year follow-up 
Longitudinal subjects 
n = 939 
Never Obese 
baseline BMI < 30 Kg/m2
follow-up BMI < 30 Kg/m2
n = 132 
Always Obese 
baseline BMI ≥ 30 Kg/m2
follow-up BMI ≥ 30 Kg/m2
n = 111 
Becoming Obese 
baseline BMI < 30 Kg/m2
follow-up BMI ≥ 30 Kg/m2
n = 30 
Becoming Non Obese 
baseline BMI ≥ 30 Kg/m2
follow-up BMI < 30 Kg/m2
reference category ∆FEV1 ↓ (– 9 mL) 
∆FVC ↓ (– 65 mL) 
∆VC ↓ (– 109 mL)
∆FEV1 ↓ (– 111 mL) 
∆FVC ↓ (– 122 mL) 
∆VC ↓ (– 155 mL)
∆FEV1 ↑ (+ 93 mL) 
∆FVC ↑ (+ 180 mL) 
∆VC ↑ (+ 48 mL)
Figure 2 Study subjects by longitudinal categories of obesity and corresponding mean variations of DFEV1, DFVC, and DVC (in
milliliters) with respect to the reference category ‘‘Never obese’’, adjusted for baseline gender, age, and smoking habit in the linear
regression models reported in Table 3.
F. Pistelli et al.678comparison to others, even though no results on this analysis
was reported. In a cohort of 181 workers followed-up forX6
years, Morgan and Reger18 showed that, regardless the
smoking habit, the subjects who lost weight showed a
smaller annual decrement in the FEV1 than those who gained
it (e.g., 0.029 vs. 0.039 L in non-smokers), even though
the magnitude of weight change yielding such effect was not
provided.
It is to point out that obesity is an important determinant
of asthma, particularly for adults,19 and overweight and
obesity have been recently demonstrated to be associated
with a dose-dependent increase in the probability of
incident asthma in both genders.20 Thus, the effect of
changes in obesity status on lung function decline may have
implications for public health, as weight-control programs
might be also considered in relation to such a chronic airway
disease.Limitations of the study
BMI was taken as a surrogate of obesity, even though it is
known that what counts to decrease lung volume in obesity is
fat distribution (upper body vs. lower body)21 and tissue
composition (fat vs. lean mass).22 Yet, BMI is a gross
parameter largely used in epidemiological studies for its
simplicity and practicability and gives us also the possibility to
compare our findings with those reported in the literature.
We recognize that co-morbidities, such as diabetes and
chronic heart failure, may affect lung function and its
decline in obesity. However, according to the available
information in our population, the rate of co-morbidities
was similar across groups, thus suggesting that differences in
decline were primarily caused by the obesity.
Lacking of a specific temporal question, our study does
not allow to know when the changes in body weight occurred
ARTICLE IN PRESS
Obesity and lung function decline 679during the 8-year period. In a future repetition of the study,
it would be helpful to yearly monitoring the weight pattern
in order to understand how long it takes for a variation in
BMI to modify the lung function decline in real life.
We acknowledge the small range of BMI and its variations
over time in our study. If on one side this prevents us from
extrapolating our analysis to massive obesity, on the other
hand it documents the importance of even small changes in
BMI in impairing lung function over time.
Few subjects were included in the BNO category as
compared with those included in the BO category, possibly
limiting the power of the statistical analyses. However, this
distribution among the longitudinal categories of obesity
reflects the well-known trend in weight changes observed
over time in the western countries.Patho-physiological interpretation of the results
Obesity is known to cause a decrease in operational lung
volume, thus gradually reducing the expiratory flow reserve
within the tidal breathing range until flow limitation
conditions and dyspnea occur, especially in the supine
posture or with minimal physical activity.7,23 Very recent
studies have hypothesized that such a decrease of the
operational lung volume may be one of the potential
mechanisms explaining the observed link between obesity
and bronchial asthma.3
In animal models, mechanical ventilation at low lung
volume results in expiratory airflow limitation and inflam-
matory damage of the small airways, with denudation of the
epithelium and sloughing and rupture of the alveolar
attachments to the adventitia.24,25 In a way, obesity is
similar to ventilating small animals at low lung volume. The
shear stress applied to the airways with the cyclic collapse
on tidal expiration and the following opening on inspiration
might lead to airway inflammation and repair/remodeling
processes, and rupture of the alveolar attachments to the
adventitia. However, considering the irreversible nature of
such damages, this hypothesis partly contrasts with the
reversible nature of lung function decline observed in this
study with weight loss.
The reversibility of the accelerated decline in lung
function with loosing weight speaks in favor of other factors
that affect lung function decline as obesity persists. Firstly,
obese individuals breathe with smaller tidal volume than
controls and higher breathing frequency.26 Breathing with
low tidal volumes results in the conversion of rapidly cycling
actin–myosin bridges to slow cycling latch bridges,27 a
condition expected to increase airway smooth muscle (ASM)
tone and thus decrease airways size. Whether this mechan-
ism contributes to explain our results is not known because
of a concomitant increase in breathing frequency, which is
capable of offsetting the increase in bronchial tone
occurring when cyclic lengthening is reduced.28 Secondly,
the inability to expand the lung sufficiently to total lung
capacity with large breaths4,29 might gradually impair
bronchial tone over time, thus contributing to exaggerate
the observed lung function decline. Simulation of chest wall
constraint with strapping has indeed shown that this may be
the case.30 Thirdly, the decline in lung function in obesity
could be the result of a plastic adaptation of the ASM to ashort length, as demonstrated by in vitro studies,31 and
suggested by the greater response to a constrictor agent
observed in healthy humans after decreasing lung vo-
lumes.30,32
Interestingly, we noted that the decline in FEV1 but not in
FVC or VC in AO was significantly less than that of BO. We
speculate that this could be due to the increase in lung
elastic recoil reported in obesity.33 Whereas the increased
lung elasticity is expected to increase maximum flow and
thus the FEV1,
34 it has the opposite effect on vital capacity
as the result of a decrease in total lung capacity greater
than the decrease in residual volume.4,29
Conclusions
Over a period of 8 years, remaining or becoming obese
accelerates lung function decline, while becoming non-
obese decreases it. On the basis of existing evidences and
present results, it appears advisable that lung function
measurements be routinely performed during weight-con-
trol programs, to assess the effects of weight changes on
respiratory health over time.
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